← Leaderboards
Nikola Lazar Vujanovic
University Of Pittsburgh At Pittsburgh
$4,156,485
Attributed
$4,156,485
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $357.4K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$4,156,485 · 3
VA$0 · 1
By mechanism
R01$3,326,297 · 2
P60$830,188 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jiantao Pu$7,235,980
- Margaret M Byrne$3,575,691
- Eugene N Myers$0
- Elain M Elder$646,615
- Joel L Weissfeld$8,317,064
Others in their field
Top investigators on “Natural Killer Cells”
- Barton F Haynes · Duke University$112,979,211
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Craig B Thompson · Sloan-Kettering Inst Can Research$42,638,329
- Selwyn M Vickers · University Of Alabama At Birmingham$41,029,054
- James C. Paulson · Scripps Research Institute$39,353,775
Research focus
Natural Killer CellsTumor Necrosis Factor AlphaCytotoxic T LymphocyteNeoplasm /Cancer ImmunologyApoptosisClinical ResearchHuman SubjectSquamous Cell CarcinomaGene ExpressionOral Pharyngeal NeoplasmDendritic CellsNeoplastic TransformationTissue /Cell CultureCytokine ReceptorsCytokineMalignant NeoplasmsInvestigationMediatingBaseGenesCellsLeadGrowthMediator Of Activation Protein
Grant awards (21)
Defining ADAM Sheddase Activities as Lung Cancer Biomarkers$0
I01 · FY2015 · VA · contact PI
Defining ADAM Sheddase Activities as Lung Cancer Biomarkers$0
I01 · FY2014 · VA · contact PI
Defining ADAM Sheddase Activities as Lung Cancer Biomarkers$0
I01 · FY2013 · VA · contact PI
NK cell-dendritic cell interaction cancer$339,113
R01 · FY2011 · DE · contact PI
NK cell-dendritic cell interaction cancer$349,688
R01 · FY2010 · DE · contact PI
NK cell-dendritic cell interaction cancer$353,306
R01 · FY2009 · DE · contact PI
NK cell-dendritic cell interaction cancer$353,388
R01 · FY2008 · DE · contact PI
NK cell-dendritic cell interaction cancer$357,399
R01 · FY2007 · DE · contact PI
Impaired Tumoricidal Activity Of DCs in HNC Patients$308,007
R01 · FY2006 · DE · contact PI
Impaired Tumoricidal Activity Of DCs in HNC Patients$315,478
R01 · FY2005 · DE
Impaired Tumoricidal Activity Of DCs in HNC Patients$315,535
R01 · FY2004 · DE
Impaired Tumoricidal Activity Of DCs in HNC Patients$316,639
R01 · FY2003 · DE
Impaired Tumoricidal Activity Of DCs in HNC Patients$317,744
R01 · FY2002 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$162,420
P60 · FY2002 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$162,420
P60 · FY2002 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$171,464
P60 · FY2001 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$162,420
P60 · FY2001 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$171,464
P60 · FY2000 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$0
P60 · FY2000 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$0
P60 · FY2000 · DE
TNF FAMILY LIGANDS AND ORAL CARCINOMA$0
P60 · FY2000 · DE